Evidence map›Paper›PMID 37080722›Full record

ArticleAJNR. American journal of neuroradiology2023

Critical Appraisal of Artificial Intelligence-Enabled Imaging Tools Using the Levels of Evidence System.

N Pham, V Hill, A Rauschecker, Y Lui, S Niogi, C G Fillipi, P Chang, G Zaharchuk, M Wintermark

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

N PhamFrom the Department of Radiology (N.P., G.Z.), Stanford School of Medicine, Palo Alto, California pham.nancy@gmail.com.ORCID 0000-0002-8975-1761
V HillDepartment of Radiology (V.H.), Northwestern University Feinberg School of Medicine, Chicago, Illinois.ORCID 0000-0001-9146-9370
A RauscheckerDepartment of Radiology (A.R.), University of California, San Francisco, San Francisco, California.ORCID 0000-0003-0633-9876
Y LuiDepartment of Radiology (Y.L.), NYU Grossman School of Medicine, New York, New York.ORCID 0000-0002-9984-9164
S NiogiDepartment of Radiology (S.N.), Weill Cornell Medicine, New York, New York.ORCID 0000-0002-6432-0017
C G FillipiDepartment of Radiology (C.G.F.), Tufts University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-4565-2614
P ChangDepartment of Radiology (P.C.), University of California, Irvine, Irvine, California.ORCID 0000-0001-7645-7865
G ZaharchukFrom the Department of Radiology (N.P., G.Z.), Stanford School of Medicine, Palo Alto, California.ORCID 0000-0001-5781-8848
M WintermarkDepartment of Neuroradiology (M.W.), The University of Texas MD Anderson Cancer Center, Houston, Texas.ORCID 0000-0002-6726-3951

Funding

TR&D 4: Revealing Microstructure: Biophysical modeling and validation for discovery and clinical careP41EB017183 · NIBIB · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Christopher M Collins · 2014 to 2026
$19.3M
NIBIB NIH HHS P41 EB017183
6 · The paper itself

Abstract

Clinical adoption of an artificial intelligence-enabled imaging tool requires critical appraisal of its life cycle from development to implementation by using a systematic, standardized, and objective approach that can verify both its technical and clinical efficacy. Toward this concerted effort, the ASFNR/ASNR Artificial Intelligence Workshop Technology Working Group is proposing a hierarchal evaluation system based on the quality, type, and amount of scientific evidence that the artificial intelligence-enabled tool can demonstrate for each component of its life cycle. The current proposal is modeled after the levels of evidence in medicine, with the uppermost level of the hierarchy showing the strongest evidence for potential impact on patient care and health care outcomes. The intended goal of establishing an evidence-based evaluation system is to encourage transparency, foster an understanding of the creation of artificial intelligence tools and the artificial intelligence decision-making process, and to report the relevant data on the efficacy of artificial intelligence tools that are developed. The proposed system is an essential step in working toward a more formalized, clinically validated, and regulated framework for the safe and effective deployment of artificial intelligence imaging applications that will be used in clinical practice.

Indexed as

Artificial IntelligenceDiagnostic ImagingHumans

Identifiers

PMID37080722
PMCPMC10171388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.